Go Therapeutics' Corporate Minority Round

Go Therapeutics raised a round of funding on August 16, 2017. Investors include Salubris Pharmaceuticals.

GO Therapeutics solves the key challenge of tumor-specificity to bring more targeted immunotherapy to cancer patients. By making antibodies to hybrid antigens combining a tumor's up-regulated protein …

Articles about Go Therapeutics' Corporate Minority Round: